President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of ...
The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...
Ozempic (injectable semaglutide) is a once-weekly treatment indicated as an add-on to diet and exercise for adults with uncontrolled Type 2 diabetes mellitus (T2DM).
Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific pricing, demand in India & quality. “India is not a ...
Newspoint on MSN
Weight loss medicines: Weight loss medicines in 2026, which medicines are available in India?
Weight loss medications like Ozempic are bringing new hope for weight loss in India on December 12, 2025. Learn about Ozempic ...
A spokesperson for Novo Nordisk, the manufacturer of Wegovy, said: “Wegovy is indicated for weight management, including ...
Retatrutide, Eli Lilly’s triple-hormone obesity drug, delivers up to 28.7% weight loss and major knee pain relief in ...
Millions of Americans have successfully lost weight with semaglutides, the game-changing class of drugs that includes Ozempic ...
YOU may be keen to shed pounds from your waistline with fat jabs, but forking out the monthly bill is less appealing – ...
Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback